It is a cliché that the stock market runs in cycles. This is especially the case given that statistically, the markets spend as much as 80% of the time in
It is a cliché that the stock market runs in cycles. This is especially the case given that statistically, the markets spend as much as 80% of the time in
The Board of Dev Clever announces today that the Company intends to submit a request to the Financial Conduct Authority (“FCA”) for the cancellation of the listing of the Company’s
In an event which is so far unique given the ridiculously high minimum market cap requirement of £30m for the Standard List of the LSE, Hydrogen Utopia International (HUI), a
Poolbeg Pharma (POLB), a clinical-stage infectious disease pharmaceutical company, announced that further to the Option.
East Star Resources (EST), the Kazakhstan-focused explorer, announced the results of analysis of rock chips collected across the company’s five volcanogenic massive sulphide Rudny Altai belt licences from geological reconnaissance
The momentum behind the contract wins at Open Orphan (ORPH), a specialist contract research organisation, grows not only in frequency, but magnitude.
While there may be some hope now for an unlikely breakout for blue chips in terms of the FTSE 100, getting back to where they were at the start of
Dev Clever, a leading developer of online and immersive career guidance, learning and development platforms, is pleased to provide an update on the comprehensive agreement with Veative Labs Pte Ltd
Another day, another update from Love Hemp (LIFE), the CBD and Hemp product suppliers, announced the issue of shares as settlement of the final deferred consideration of £2,000,000. 65,000,000 new
Zak Mir takes a charting view on some of the most followed stocks on the London market. Today’s selection includes Avacta, Abingdon, Asimilar, Anexo, Caspian, Dev, Genedrive, Mila, Online Blockchain,
Zak Mir takes a technical perspective to some of the most followed small caps on the London market. Today’s selection includes Argo, Bens, Atlantic, Chariot, Dev, Eurasia, i3, Life Science,